Compass Therapeutics, Inc.
CMPX- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001738021
In the last 90 days, Compass Therapeutics, Inc. insiders filed 1 open-market purchase and 0 sales; 215 institutions reported holding it in 13F filings for Q2 2026, worth $363.4M in total; no superinvestor holds it.
Q3 2023 vs. Q2 2023
How the institutions holding Compass Therapeutics, Inc. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Q3 2023 | Change |
|---|---|---|---|
| Holders | 73 | 76 | +3 |
| Shares | 90.5M | 89.7M | −758.3K (−0.8%) |
| Value | $287.7M | $176.7M | −$110.9M (−38.6%) |
New holders (8)
Institutions that held Compass Therapeutics, Inc. at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Pale Fire Capital SE | 45,155 | $89.0K | 0.01% |
| Two Sigma Advisers, LP | 38,600 | $76.0K | 0.00% |
| SG Americas Securities, LLC | 38,807 | $76.0K | 0.00% |
| Renaissance Technologies LLC | 26,800 | $53.0K | 0.00% |
| Two Sigma Investments, LP | 25,700 | $50.6K | 0.00% |
| New Capital Management LP | 24,243 | $47.8K | 0.02% |
| Verition Fund Management LLC | 15,515 | $30.6K | 0.00% |
| Principal Financial Group Inc | 11,972 | $23.6K | 0.00% |
Sold out (5)
Institutions that held Compass Therapeutics, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| LMR Partners LLP | 80,692 | $256.6K |
| Susquehanna International Group, LLP | 25,507 | $81.1K |
| XTX Topco Ltd | 10,992 | $35.0K |
| State of Wisconsin Investment Board | 11,601 | $34.6K |
| Aquatic Capital Management LLC | 100 | $0 |